Xiangyu D. Li

Stockholm, AB 17165, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity.

Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity.

Journal: Neurobiology of disease

Published: November 25, 2025

Systematically identification of survival-associated eQTLs in a Japanese kidney cancer cohort.

Systematically identification of survival-associated eQTLs in a Japanese kidney cancer cohort.

Journal: PLoS genetics

Published: January 08, 2025

Corrigendum to "Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning" [eBioMedicine, 2022;83:104214].

Corrigendum to "Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning" [eBioMedicine, 2022;83:104214].

Journal: EBioMedicine

Published: June 29, 2024

Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach.

Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach.

Journal: International journal of molecular sciences

Published: June 24, 2024

Identification of SPP1 + macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics.

Identification of SPP1 + macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics.

Journal: Frontiers in immunology

Published: June 09, 2024

Retraction notice to "Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases" [Life Sci. 314 (2023) 121325].

Retraction notice to "Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases" [Life Sci. 314 (2023) 121325].

Journal: Life sciences

Published: May 18, 2024

A resource for whole-body gene expression map of human tissues based on integration of single cell and bulk transcriptomics.

A resource for whole-body gene expression map of human tissues based on integration of single cell and bulk transcriptomics.

Journal: Genome biology

Published: May 07, 2024

Novel drug targets and molecular mechanisms for sarcopenia based on systems biology.

Novel drug targets and molecular mechanisms for sarcopenia based on systems biology.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 24, 2024

Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease.

Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: February 26, 2024

Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial.

Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial.

Journal: Brain communications

Published: November 02, 2023

Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators.

Longitudinal metabolomics analysis reveals the acute effect of cysteine and NAC included in the combined metabolic activators.

Journal: Free radical biology & medicine

Published: March 13, 2023

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.

Journal: Journal of translational medicine

Published: February 26, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026